Actuate Therapeutics, Inc Common stock
Price & Volume
Stats
See more52W Range | $0.33-$7.90 |
Market Cap | $18.8M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.89 |
News
See moreYahoo Finance • 23 hours ago
Actuate Therapeutics to Present Promising Preclinical Data Demonstrating Antitumor and Immune Activation Activity of Elraglusib Oral Tablet in Advanced Melanoma Models at ENA 2026
Yahoo Finance • 4 months ago
Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus
Yahoo Finance • 8 months ago
Actuate Therapeutics to Present at The Citizens Life Sciences Conference
About
CEO | Mr. Daniel M. Schmitt |
Address | 1751 River Run, Fort Worth, TX, United States, 76107 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |